Liquidity	9 Months Ended
Sep. 30, 2025
Liquidity [Abstract]
Liquidity	Note 2 Liquidity: The Company has historically experienced recurring losses and negative working capital and has been dependent on raising capital from the sale of securities in order to continue to operate, which raises substantial doubt regarding the Company’s ability to continue as a going concern. In October 2021, the Company entered into an equity distribution agreement with an investment bank under which the Company may sell up to an additional $5.1 million of its common stock in registered “at-the-market” offerings, subject to certain limitations. Additionally, the Company’s lender has paused the minimum net revenue covenant for quarterly periods through September 30, 2026 (see Note 16, Subsequent Events). Based on our current business plan, management believes that the Company’s cash and cash equivalents of $7.1 million, net proceeds of $1.4 million raised under the equity distribution agreement in October 2025, the anticipated revenues from the sale or use of its products and operating expense management will be sufficient to satisfy the Company’s working capital needs, capital asset purchases, outstanding commitments and other liquidity requirements associated with its existing operations for at least the next 12 months following the date of the issuance of these condensed consolidated financial statements, alleviating the factors that raised substantial doubt regarding the Company’s ability to continue as a going concern.

The Company has historically experienced recurring losses and negative working capital and has been dependent on raising capital from the sale of securities in order to continue to operate, which raises substantial doubt regarding the Company’s ability to continue as a going concern. In October 2021, the Company entered into an equity distribution agreement with an investment bank under which the Company may sell up to an additional $5.1 million of its common stock in registered “at-the-market” offerings, subject to certain limitations. Additionally, the Company’s lender has paused the minimum net revenue covenant for quarterly periods through September 30, 2026 (see Note 16, Subsequent Events). Based on our current business plan, management believes that the Company’s cash and cash equivalents of $7.1 million, net proceeds of $1.4 million raised under the equity distribution agreement in October 2025, the anticipated revenues from the sale or use of its products and operating expense management will be sufficient to satisfy the Company’s working capital needs, capital asset purchases, outstanding commitments and other liquidity requirements associated with its existing operations for at least the next 12 months following the date of the issuance of these condensed consolidated financial statements, alleviating the factors that raised substantial doubt regarding the Company’s ability to continue as a going concern.